ACCREDITATION STATEMENT
30th Clinical Applications for Age Management Medicine Conference
This activity has been approved for 26 AMA PRA Category 1 Credits
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Age Management Medicine Group (AMMG). The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 26 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in this activity.
The ACCME defines a “Commercial Interest” as any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.
Nursing Statement
The Foundation for Care Management is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 26 Nursing contact hour(s).
This conference was supported by an educational grants from Belmar Pharmacy, Carnosyn and Fountain Life
Course OBJECTIVES
- Describe the essential scientific evidence-based information for the use of approved Hormones in Age Management Medicine and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.
- Describe and discuss issues which occur related to Hormone Therapy such as the use of Natural Aromatease Inhibitors, effects of Testosterone on Prostate Cancer and Post Finasteride Syndrome.
- Describe evidence-based information for the diagnosis and treatment of Traumatic Brain Injury and how to clinically apply this knowledge to individualized patient treatment plans. and summarize the available scientific literature discussing the primary traumas and secondary effects of inflammation in patients with TBI.
- Explain evidence-based information on Precision Medicine applications such as Epigenetic Methylation, Epigenetics and implications for Cardiovascular Disease, and Stem Cell Therapy for Immune System Restoration
- Compare and discuss essential scientific evidence-based information on the use of Food as Medicine and various approaches to diet and nutrition in an effort to provide for superior patient outcomes.
- Discuss new scientific evidence-based information for disease prevention and intervention, specifically for Covid-19 and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.
FACULTY/Planner — DISCLOSURES
The Foundation for Care Management (FCM) requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by The Foundation for Care Management (FCM) for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Conference Planning Committee – Disclosure
Mary L. Corry, R.N. — No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
No member of The Foundation for Care Management or the Age Management Medicine Group has any relevant financial relationships to disclose in regards to this activity.
Faculty – Disclosure
Arden Anderson, Ph.D., D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Joseph E. Bosiljevac, Jr. M.D., Ph.D. — No Relevant Relationships with a Commercial Interest to Disclose
Katrina J. Breece, M.S. — No Relevant Relationships with a Commercial Interest to Disclose
William Clearfield, D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Florence Comite, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Carolyn DeLucia, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Elliott Dintez, M.D., ABFN — No Relevant Relationships with a Commercial Interest to Disclose
Angela DeRosa, D.O. — Belmar Pharmacy, Medical Director and Hormone Health Institute, Founder
Derrick DeSilva, Jr., M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Galen M. Eversole, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Jay R. Hoffman, Ph.D. — Funding for Research Presented was funded in part by Carnosyn & Carnosyn Brand
Robert Kominiarek, D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Melissa Loseke-Ablett, D.O. — No Relevant Relationships with a Commercial Interest to Disclose
Luis Martinez, M.D., MPH — No Relevant Relationships with a Commercial Interest to Disclose
Steven Masley, M.D. — Author, The Mediterranean Method
Abraham Morgenthaler, M.D.— Consultant, Antares, Acerus, Marius, Advisory Committee Bayer, Research Grant Endo
Daniel Purser, M.D.— No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. — No Relevant Relationships with a Commercial Interest to Disclose
Betty Wedman-St. Louis, Ph.D.,RD— No Relevant Relationships with a Commercial Interest to Disclose